TGF-beta and IL-17 serum levels and specific immunotherapy.

@article{Ciprandi2009TGFbetaAI,
  title={TGF-beta and IL-17 serum levels and specific immunotherapy.},
  author={Giorgio Ciprandi and Mara De Amici and Simone Negrini and Gianluigi L. Marseglia and Maria Angela Tosca},
  journal={International immunopharmacology},
  year={2009},
  volume={9 10},
  pages={1247-9}
}
Two new T cell subsets may be involved in allergic rhinitis (AR) pathogenesis: Th17 and T regulatory cells, mainly producing IL-17 and TGF-beta respectively. Successful Sublingual Immunotherapy (SLIT) induces relevant immunological changes, thus the aim of this study was to evaluate serum IL-17 and TGF-beta levels in AR patients treated with SLIT for 2 years. Patients' blood samples were collected before initiating SLIT (baseline), three months after the end of the first pre-seasonal SLIT… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-4 of 4 extracted citations

Neurobiology of Respiration

Advances in Experimental Medicine and Biology • 2013
View 4 Excerpts
Highly Influenced

Th17 polarization and upper airways: new insights.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology • 2015

Similar Papers

Loading similar papers…